Skip to main content
ADBIOTECH Co.,Ltd. logo

ADBIOTECH Co.,Ltd. — Investor Relations & Filings

Ticker · 179530 ISIN · KR7179530001 KO Manufacturing
Open in API
Filings indexed 414 across all filing types
Latest filing 2025-10-31 Legal Proceedings Report
Country KR South Korea
Listing KO 179530

About ADBIOTECH Co.,Ltd.

http://www.adbiotech.com

ADBIOTECH Co., Ltd. is a biotechnology company specializing in the development and commercialization of immune antibodies. The company's core competency is IgY (Immunoglobulin in Yolk) technology, which utilizes antibodies derived from eggs to create alternatives to conventional vaccines and antibiotics. Its product portfolio targets the livestock, aquaculture, and human health sectors, with applications for disease prevention and treatment in animals like salmon and shrimp, as well as human-focused developments for conditions related to Helicobacter pylori and cholesterol. The company manages the entire value chain from research and development to production and sales. ADBIOTECH is also expanding its technological capabilities into VHH (nanobody) technology, with a strategic focus on the global companion animal market.

Recent filings

Filing Released Lang Actions
소송등의판결ㆍ결정
Legal Proceedings Report Classification · 100% confidence The document is a legal proceeding update regarding the withdrawal of a provisional injunction application related to the CEO's duties. It includes case details, parties involved, court information, and dates. There is no financial data, earnings information, or management discussion. The content is focused on legal matters and court decisions. Therefore, it fits the category of Legal Proceedings Report (LTR). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS.
2025-10-31 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 95% confidence The document is a detailed disclosure about the issuance and amendment of convertible bonds (전환사채권 발행결정) by the company (주)애드바이오텍. It includes specifics such as issuance dates, conversion ratios, conversion prices, put options, repayment schedules, and the purpose of the capital raised (operating funds). The document is titled '주요사항보고서' which translates to 'Material Information Report' or 'Major Event Report' and is addressed to the Financial Supervisory Service and Korea Exchange, indicating it is a regulatory disclosure. The content is focused on capital raising through convertible bonds and changes to the terms of the issuance. It is not a full financial report, earnings release, or management discussion, but rather a regulatory announcement about financing activity. Therefore, the most appropriate classification is 'Capital/Financing Update' (CAP). The document length is substantial and contains detailed financial terms related to capital structure changes, supporting this classification with high confidence.
2025-10-31 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 95% confidence The document is a detailed disclosure about the issuance and correction of terms related to convertible bonds (전환사채권 발행결정) by the company (주)애드바이오텍. It includes specifics on the bond issuance amount, conversion ratios, conversion prices, use of proceeds, early redemption options, and other detailed financial and contractual terms. The document is a regulatory filing reporting a material event concerning capital raising through convertible bonds. It is not a full financial report like an Annual Report or Interim Report, nor is it a simple announcement of a report publication. It is a detailed capital/financing update about the issuance and correction of convertible bonds. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (13,487 characters) supports it being a substantive filing rather than a brief announcement.
2025-10-31 Korean
주요사항보고서(자기신주인수권부사채만기전취득결정)
Capital/Financing Update Classification · 95% confidence The document is titled '주요사항보고서(자기신주인수권부사채만기전취득결정)' which translates to 'Material Event Report (Decision to Acquire Convertible Bonds Before Maturity)'. It is addressed to the Financial Services Commission and Korea Exchange, indicating a regulatory filing. The content details the decision to acquire bonds before maturity, including bond types, amounts, acquisition dates, and reasons. It also references related prior disclosures and includes detailed transaction information. The document length is 2463 characters, which is relatively short and focused on a specific event rather than a comprehensive financial report. This type of filing corresponds to a material event or regulatory announcement about financing activities, specifically about bond acquisition before maturity. According to the filing definitions, this fits best under 'Capital/Financing Update (CAP)' as it updates on company financing activities and capital structure changes. It is not an annual or interim report, audit report, or earnings release, nor is it a simple announcement of a report publication. Therefore, the classification is CAP with high confidence.
2025-10-30 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is titled '주요사항보고서(전환사채권 발행결정)' which translates to 'Material Information Report (Decision to Issue Convertible Bonds)'. It contains detailed information about the issuance of convertible bonds, including conversion ratios, conversion prices, issuance amounts, terms, and conditions. The document is addressed to the Financial Services Commission and Korea Exchange, indicating it is a regulatory disclosure. The content focuses on the issuance and terms of convertible bonds, which is a capital raising activity. There is no indication that this is a full financial report, earnings release, or management discussion. It is not a notice of dividend, nor a voting result or AGM material. The document is substantive and detailed, not a brief announcement or a certification. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities such as bond issuance.
2025-10-29 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서(약식)' which translates to 'Report on Large Shareholding Status (Abbreviated)'. It details the shareholding changes of a significant shareholder, including the number of shares held, percentage ownership, changes in holdings, and related information. The document references specific dates and shareholding percentages, and it is a regulatory disclosure related to major shareholding notifications. There is no indication that this is an annual report, earnings release, or any other financial report type. It is a notification of changes in significant share ownership levels, consistent with the definition of Major Shareholding Notification (MRQ). The document length is 6190 characters, which is substantive and contains detailed data, not just an announcement or certification. Therefore, the correct classification is MRQ with high confidence.
2025-10-28 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.